We are live on ! Find out more
ALT icon

Altimmune

72 hedge funds and large institutions have $285M invested in Altimmune in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 15

100% more capital invested

Capital invested by funds: $143M → $285M (+$143M)

26% more funds holding

Funds holding: 5772 (+15)

23% more call options, than puts

Call options by funds: $5.71M | Put options by funds: $4.64M

20% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 15

0.28% more ownership

Funds ownership: 66.27%66.54% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
72
Holders Change
+15
Holders Change %
+26.32%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
18
Reduced
15
Closed
15
Calls
$5.71M
Puts
$4.64M
Net Calls
+$1.07M
Net Calls Change
-$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
76
Premier Asset Management
Illinois
-$273K -25,515 Closed
ECM
77
ExodusPoint Capital Management
New York
-$251K -23,400 Closed
HSBC Holdings
78
HSBC Holdings
United Kingdom
-$228K -21,326 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
-$283K -14,000 Closed
JP Morgan Chase
80
JP Morgan Chase
New York
-$140K -13,065 Closed
LOPW
81
Live Oak Private Wealth
North Carolina
-$107K -10,000 Closed
OIA
82
Optimum Investment Advisors
Illinois
-$21K -2,000 Closed
Fidelity Investments
83
Fidelity Investments
Massachusetts
-$17K -1,600 Closed
US Bancorp
84
US Bancorp
Minnesota
-$12K -1,145 Closed
TFS
85
TrustCore Financial Services
Tennessee
-$3K -250 Closed

ALT Hedge Fund Activity: Q3 2020 in Review

72 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2020, worth a combined $285M — up 100% from $143M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ALT positions and 15 closed out — a net gain of 15 holders — while 18 added to existing stakes and 15 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $40M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $8.35M sold.

  • 72 institutional investors held Altimmune (ALT) as of Q3 2020, up from 57 in Q2 2020.
  • Funds reported $285M of Altimmune stock for Q3 2020, up 100% quarter-over-quarter.
  • 30 funds opened new Altimmune positions in Q3 2020 and 15 closed out, a net change of +15 holders.
  • The largest Altimmune buyer in Q3 2020 was Avoro Capital Advisors, an estimated $40M added.
  • The largest Altimmune seller in Q3 2020 was Hudson Bay Capital Management, an estimated $8.35M sold.

Based on aggregated 13F filings for Q3 2020.